Drug
emapalumab-lzsg
Marketed as GAMIFANT.
Generic name
emapalumab-lzsg
Brand names
GAMIFANT
First FDA approval
2018-11-20
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761107 | GAMIFANT | 2018-11-20 | NOVIMMUNE S.A. |
Manufacturers
NOVIMMUNE S.A.
Frequently asked questions
When was emapalumab-lzsg FDA approved?
Earliest FDA approval on record: 2018-11-20.
What brand names are sold as emapalumab-lzsg?
GAMIFANT.
Sources
Appeal a emapalumab-lzsg denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com